Change Theme
CNBC TV18
Fri, Sep 27, 2024
Goldman Sachs expects Gland Pharma shares to fall back to their IPO price
Goldman Sachs is anticipating Gland Pharma's profitability to face headwinds. It has highlighted five factors as to why it believes so.